MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Formation of Strategic Advisory Board

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced the formation of its Strategic Advisory Board. According to the update, the group of respected business leaders, which includes inaugural board members John Ruffolo, Meg Lovell and Philip Donne, will provide guidance to Canopy Rivers’ executive team as it continues to build and strengthen its global portfolio of leading cannabis companies. “We have assembled a group of outstanding individuals with exceptional track records as leaders in their respective industries,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “The Strategic Advisory Board will play an important role in providing guidance and insight to Canopy Rivers as we pursue our global growth strategy. Together, we look forward to building the cannabis industry of tomorrow, today.”

To view the full press release, visit http://ibn.fm/cBm34

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Pressure BioSciences Inc.’s (PBIO) PCT Platform Identified as Pivotal for Cancer Biomarker Discovery and Potential Use in Clinical Diagnostics

Pressure BioSciences Inc. (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based technology and products to the worldwide life sciences and other industries, today announced the publication of two scientific journal articles led by independent teams of scientists in China and Australia. Per the update, the articles reported excellent results with PBI’s Pressure Cycling Technology (“PCT”) platform in processing preserved formalin-fixed paraffin-embedded (“FFPE”) and fresh frozen biopsy tissue samples for discovery and elucidation of cancer biomarkers, as well as potential use in clinical diagnostics based upon these markers. “It is estimated (Nature volume 448, pages 959–962, 23 August 2007) that well over one billion archival FFPE tissue samples exist in pathology and other laboratories worldwide. We believe there are millions of new FFPE tissue samples processed and stored each year,” Pressure BioSciences President and CEO Richard T. Schumacher said in the news release. “These samples offer the promise of unveiling invaluable information that can lead to the development of new treatments, cures, and preventive measures for cancer and many other diseases. However, up to now, it has been very difficult to extract this information from biomolecules in FFPE samples.”

To view the full press release, visit http://ibn.fm/QhPt0

About Pressure BioSciences Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. The company’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). PBIO’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired PreEMT technology from BaroFold, Inc. to allow entry into the biologics contract research services sector, and (2) the use of its recently-patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room temperature stable low-acid liquid foods that cannot be effectively preserved using existing non-thermal technologies. For more information, visit the company’s website at www.PressureBiosciences.com

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

Earth Science Tech Inc.’s (ETST) CBD Oil is Unique in the Industry

• Earth Science Tech is looking to expand its line of work through two wholly owned subsidiaries
• Its subsidiaries focus on R&D and product development
• The company recently outlined a five-year marketing and manufacturing plan

Earth Science Tech Inc. (OTCQB: ETST) is an aspiring biotech company engaged in the development of cannabinoid-based products and the research and development of medical devices and pharmaceuticals. Using the supercritical CO2 liquid extraction, isolation and micron filtration process, the company manufactures 100 percent natural CBD oil. This pure, easily digested, rich CBD hemp oil is unique to the nutraceuticals industry and represents a significant asset to ETST.

Earth Science Tech is currently looking to expand its operations in the areas of CBD product development and R&D of medical devices and pharmaceuticals through its two wholly owned subsidiaries: Earth Science Pharma Inc. and Cannabis Therapeutics Inc.

Earth Science Pharma Inc. is focused on the research and development of low-cost medical devices and vaccines that benefit women’s health. The company recently introduced its first medical device, MSN-2, a home kit designed for the detection of STIs such as chlamydia. The company has named this kit Hygee. By circumventing the need for laboratory analysis, ETST anticipates that the kit will empower women across the world, giving them a low-cost, noninvasive method to meet their diagnostic health care needs (http://ibn.fm/HROu1).

Aside from Earth Science Pharma’s innovations in the diagnostic health care space, ETST has another subsidiary operating in the burgeoning cannabis industry. Cannabis Therapeutics Inc. is committed to the research and development of medicinal cannabidiol. The company also possesses a provisional application patent for a CBD product that can be used for developing medications to treat breast and ovarian cancers.

ETST recently filed a 10-K annual report with the SEC that included an outline of the company’s five-year expansion plan for manufacturing and marketing its CBD products (http://ibn.fm/JY9mT). The plan includes information about the company’s strategic preparations to scale up the production of its CBD oil, introduce new products and make its innovative hemp products available worldwide (http://ibn.fm/5OZ0R).

Earth Science Tech has teamed up with the University of Central Oklahoma to conduct research and development projects. In addition, studies from the DV Biologics Laboratory scientifically support and advance the health care benefits of the company’s high-grade hemp CBD oil. These studies show positive results regarding breast cancer and immune cells to support that ETST’s CBD oil formulation lowers cortisol and functions as a neuro-protectant, with positive-result case studies conducted through key health organizations.

“Our CBD-rich hemp oil does not contain any synthetic cannabinoids and is not an isolate,” the SEC report noted. “It contains everything that is naturally occurring in the original industrial hemp plant. With our high-quality, CBD-rich hemp oil you benefit from the natural interaction of phytonutrients in their balanced wide-ranging form that may offer the most benefit for overall wellness.” The report further noted that the company’s “commercialized, CBD-based product line, High-Grade Full Spectrum Cannabinoids, offers seven distinct cannabinoids maximizing all the therapeutic benefits the industrial hemp plant has to offer.”

Through the innovative products offered by its two wholly owned subsidiaries, ETST is well-positioned to stay abreast of current trends in multiple markets.

For more information, visit the company’s website at www.EarthScienceTech.com

NOTE TO INVESTORS: The latest news and updates relating to ETST are available in the company’s newsroom at http://ibn.fm/ETST

About MissionIR

MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

For more information, visit www.MissionIR.com

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) Herbert Works Awarded Health Canada R&D License to Develop Cannabis-Infused Beverages

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, today announced that its portfolio company Herbert Works Ltd. has received its Health Canada research and development (R&D) license to develop branded cannabis-infused beverages. “This announcement represents a significant milestone for Herbert Works as the company continues to move quickly toward the development of exceptional and widely appealing THC-infused beverages,” Canopy Rivers President and CEO Narbe Alexandrian said in the news release. “It’s a timely achievement, as the next wave of cannabis legalization in Canada will unlock these new product offerings in a matter of months. We believe that Herbert Works is in a prime position to capitalize on the growth opportunities that ‘Cannabis 2.0′ presents for consumers that are eager to try cannabis in different formats.”

To view the full press release, visit http://ibn.fm/8tQBw

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – SRAX, Inc. (NASDAQ: SRAX) Partners with Major CPG Brands to Launch New BIGtoken Feature, BIG Rewards™

Digital marketing and consumer data management technology company SRAX (NASDAQ: SRAX) today announced its entry into new partnerships with major consumer packaged goods (“CPG”) brands to launch BIG Rewards(TM). According to the update, BIG Rewards(TM) is a new feature of SRAX’s consumer-managed data marketplace, BIGtoken, that enables marketers to engage BIGtoken’s nearly 16 million users to participate in brand research and exclusive offers. “This initiative represents one of many ways we can provide BIGtoken offerings beyond data targeting,” Kristoffer Nelson, COO of SRAX and co-founder of BIGtoken, said in the news release. “BIG Rewards(TM) addresses the need for brand research during a time when consumers’ behavior towards brands are in constant flux. BIGtoken is quickly becoming a one-stop shop, enabling brands to utilize the BIG platform for research and build digital media campaigns around deep insights.”

To view the full press release, visit http://ibn.fm/fO3iO

About SRAX

SRAX, Inc. (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels. Monetizing its data sets, SRAX is growing multiple recurring revenue streams through its various platforms. Through the BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data thereby offering everyone in the Internet ecosystem choice, transparency, and compensation. SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury, and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform. For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Commences Trading on the Toronto Stock Exchange

Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, this morning announced that its class A subordinated voting shares began trading on the Toronto Stock Exchange (the “TSX”) under the ticker symbol “RIV” as of today’s opening of the markets. According to the update, this milestone was achieved within less than one year of Canopy Rivers’ initial go-public transaction. “We are proud to join a class of issuers that includes many reputable domestic and international companies,” Narbe Alexandrian, president and CEO of Canopy Rivers, said in the news release. “We believe that graduating to the TSX will improve awareness about Canopy Rivers and enhance liquidity for our shareholders and other market participants.”

To view the full press release, visit http://ibn.fm/59zD1

About Canopy Rivers Inc.

Canopy Rivers is a unique investment and operating platform structured to pursue investment opportunities in the emerging global cannabis sector. Canopy Rivers identifies strategic counterparties seeking financial and/or operating support. Canopy Rivers has developed an investment ecosystem of complementary cannabis operating companies that represent various segments of the value chain across the emerging cannabis sector. As the portfolio continues to develop, constituents will be provided with opportunities to work with Canopy Growth Corporation (TSX: WEED, NYSE: CGC) and collaborate among themselves, which Canopy Rivers believes will maximize value for its shareholders and foster an environment of innovation, synergy and value creation for the entire ecosystem. For more information, visit the company’s website at www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

MissionIRNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) and Caliper Foods Report Positive Results from Proprietary Water-Soluble Cannabinoid Technology Study

Cannabis-focused research and development company The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium certified organic cannabis, and Caliper Foods (formerly Stillwater Foods), a best-in-class provider of water-soluble cannabinoid products, today announced the results of a preliminary human pharmacokinetic (“PK”) study . The PK study was conducted on Caliper CBD, Caliper Foods’ proprietary tasteless and odorless powder that is water soluble and can be added to almost any food or beverage. Early data shows that Caliper CBD demonstrated a 4.5-fold higher observed total bioavailability and faster onset with higher concentrations achieved, both at 15 minutes, compared to maximum concentration achieved at 45 minutes with a CBD in oil formulation. “We are delighted with these PK results as they confirm the enhanced bioavailability and consistent absorption rates of our proprietary ingredient technology, which can infuse both CBD and THC. This study confirms that consumers absorb 4.5 times more CBD with Caliper CBD than with CBD in MCT oil,” Caliper Foods Director of R&D Keith Woelfel said in the news release. “Our R&D team is working closely with TGOD on the next phase of the clinical study, which, if it confirms the PK results in additional product forms, will make Caliper Foods’ and TGOD’s product suites highly differentiated in terms of substantiated quality.”

To view the full press release, visit http://ibn.fm/vYm3i

About the Green Organic Dutchman Holdings Ltd.

The Green Organic Dutchman Holdings is a publicly traded, premium global organic cannabis company with operations focused on medical cannabis markets in Canada, Europe, the Caribbean and Latin America, as well as the Canadian adult-use market. TGOD also has organic hemp CBD oil operations in Canada, and through its wholly-owned subsidiary HemPoland distributes premium hemp CBD oil in EU. The company grows high-quality, certified organic cannabis with sustainable, all-natural principles. TGOD’s products are laboratory tested to ensure patients have access to a standardized, safe and consistent product. TGOD has a planned global capacity of 219,000 kgs. and is building 1,643,600 square feet of cultivation and processing facilities across Ontario, Quebec, Jamaica and Denmark. For more information, visit the company’s website at www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
Editor@MissionIR.com

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html